Prescription of opioids in Italy: Everything, but the morphine

Annals of Oncology

Volumn 20, Issue 5, 2009, Pages 961-962

  Bandieri, E ^a   Chiarolanza, A ^a   Luppi, M ^a   Magrini, N ^a   Marata, A M ^a   Ripamonti, C ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; FENTANYL; MORPHINE; OPIATE DERIVATIVE; OXYCODONE;

ARTICLE; CANCER PAIN; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG MARKETING; DRUG USE; HEALTH CARE QUALITY; HUMAN; MEDICAL CARE; MEDICAL EDUCATION; PRESCRIPTION; PRIORITY JOURNAL;

EID: 65549100670     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp041     Document Type: Article

References (6)

1. World Health Organization. Cancer Pain Relief. Geneva: World Health Organization 1996.
2. Hanks GW, De Conno F, Cherny N et al. Morphine and alternative opioids in cancer pain: The EAPC recommendations. Expert Working Group of the Research Network of the European Association for Palliative Care. Br J Cancer 2001; 84: 587-593.
3. European Society for Medical Oncology (ESMO) Guidelines Working Group. Management of cancer pain: ESMO Clinical Recommendations. Ann Oncol 2008; 19: Ii119-ii121.
4. Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database of Systematic Reviews 2007; (Issue 4): Art. No.: CD003868.
5. De Conno F, Ripamonti C, Brunelli C. Opioid purchases and expenditure in nine western European countries. "Are we killing off morphine?" Palliat Med 2005; 19: 179-184.
6. Chinellato A, Terrazzani G, Walley T et al. Opioids in Italy: Is marketing more powerful than the law? Lancet 2003; 362: 78.